Table 1 Demographic and clinical characteristics
Group 1 (n = 110) | Group 2 (n = 92) | Group 3 (n = 109) | P value | |
|---|---|---|---|---|
Age, years, range | 18–88 | 22–80 | 23–84 | 0.672 |
Male gender, n (%) | 56 (50.9) | 49 (53.3) | 43 (39.5) | 0.102 |
Previous history of esophagogastroduodenoscopy, n (%) | 78 (70.9) | 53 (57.6) | 57 (52.3) | 0.484 |
Indications, n (%) | 0.331 | |||
Epigastric pain | 47 (42.7) | 43 (46.7) | 35 (32.1) | |
Dyspepsia | 13 (11.8) | 16 (17.4) | 39 (35.8) | |
Nausea | 8 (7.3) | 3 (3.3) | 3 (2.8) | |
Vomit | 6 (5.5) | 2 (2.2) | 2 (1.8) | |
Heartburn | 21 (19.1) | 10 (10.9) | 14 (12.8) | |
Surveillance | 15 (13.6) | 18 (19.6) | 16 (14.7) | |
Positive H. pylori infection within 3 months, n (%) | 23 (20.9) | 13 (11.8) | 19 (17.4) | 0.459 |